CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

Seeking Alpha Healthcare
Original article

Sensus outlines shift to $250,000 average selling price as it targets a stronger second half

Positive
AI Analysis

Summary

Sensus outlines a shift to a $250,000 average selling price as it targets improved performance in the second half of the year.

Financial Highlights

Guidance

stronger second half targeting $250,000 average selling price

Importance:3/10
Sentiment:
0.50
pricing strategyguidancerevenue outlook

Read the original article

Published by Seeking Alpha Healthcare on August 14, 2026 2:18 AM

Read Original